Search results
Results from the WOW.Com Content Network
The focus of Glaxo, its manufacturer, was to gain market share "from Zantac competitors like Tagamet." [9] Cimetidine, sold under the brand name Tagamet among others, was listed in 2020 as an alternative to Zantac. [11] The company also introduced a half-strength [12] Line Extension named Zantac 75. [13]
April 1, 2020 at 3:07 PM. All Zantac products and generic versions of the heartburn medication should be taken off pharmacy shelves immediately, the Food and Drug Administration announced ...
The U.S. Food and Drug Administration (FDA) in 2020 pulled Zantac and its generic versions off the market, triggering a wave of lawsuits. The drug, approved over four decades ago, was the world's ...
In 2020, the U.S. Food and Drug Administration asked drugmakers to pull Zantac and its generic versions off the market after NDMA was found in samples of the drug.
By Brendan Pierson (Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that ...
The New Haven-based lab said its testing in 2019 revealed that Zantac, also known as ranitidine, could form a cancer-causing carcinogen known as NMDA and was therefore "unfit for human consumption."
The litigation began after the U.S. Food and Drug Administration in 2020 asked manufacturers to pull the drug off the market over concerns that ranitidine, the active ingredient in Zantac and ...
In 2020, the U.S. Food and Drug Administration asked drugmakers to pull Zantac and its generic versions off the market after a cancer-causing substance called NDMA was found in samples of the drug.